Alexander Griekspoor

Alexander Griekspoor

Auto-generated profile, based on publicly available information

Alexander Griekspoor

Department of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Cell
Verified
Journal Article
Closed access
PVP. Mathijs Voorhoeve
P. Mathijs Voorhoeve
CSCarlos le Sage
Carlos le Sage
MSMariette Schrier
Mariette Schrier
AGAd J.M. Gillis
Ad J.M. Gillis
HSHans Stoop
Hans Stoop
RAReuven Agami
Reuven Agami

1 January 2003 in Immunity
Verified
Journal Article
Closed access
EREric Reits
Eric Reits
AGAlexander Griekspoor
Alexander Griekspoor
JNJoost Neijssen
Joost Neijssen
TGTom Groothuis
Tom Groothuis
KJKees Jalink
Kees Jalink
JNJacques Neefjes
Jacques Neefjes

1 June 2004 in Cancer Cell
Verified
Journal Article
Closed access
RMRob Michalides
Rob Michalides
AGAlexander Griekspoor
Alexander Griekspoor
ABAstrid Balkenende
Astrid Balkenende
DVDesiree Verwoerd
Desiree Verwoerd
LJLennert Janssen
Lennert Janssen
JNJacques Neefjes
Jacques Neefjes

12 July 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
WZWilbert Zwart
Wilbert Zwart
AGAlexander Griekspoor
Alexander Griekspoor
VBValeria Berno
Valeria Berno
KLKim Lakeman
Kim Lakeman
KJKees Jalink
Kees Jalink
RMRob Michalides
Rob Michalides
Resistance to tamoxifen is observed in half of the recurrences in breast cancer, where the anti‐estrogen tamoxifen acquires agonistic properties for transactivating estrogen receptor α (ERα). In a previous study, we showed that protein kinase A (PKA)‐mediated phosphorylation of serine 305 (S305) of ERα results in resistance to tamoxifen. Now, we demonstrate that phosphorylation of S305 in ERα by PKA leads to an altered orientation between ERα and its coactivator SRC‐1, which renders the transcription complex active in the presence of tamoxifen. This altered orientation involves the C‐termini of ERα and SRC‐1, which required a prolonged AF‐1‐mediated interaction. This intermolecular reorientation as a result of PKA‐mediated phosphorylation of ERα‐S305 and tamoxifen binding provides a unique model for resistance to the anticancer drug tamoxifen.

1 February 2005 in Immunity
Verified
Journal Article
Closed access
WZWilbert Zwart
Wilbert Zwart
AGAlexander Griekspoor
Alexander Griekspoor
CKCoenraad Kuijl
Coenraad Kuijl
MMMarije Marsman
Marije Marsman
JRJacco van Rheenen
Jacco van Rheenen
JNJacques Neefjes
Jacques Neefjes

15 June 2009 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YSYuri Souwer
Yuri Souwer
AGAlexander Griekspoor
Alexander Griekspoor
TJTineke Jorritsma
Tineke Jorritsma
JWJelle de Wit
Jelle de Wit
HJHans Janssen
Hans Janssen
SHS. Marieke van Ham
S. Marieke van Ham
The present paradigm is that primary B cells are nonphagocytosing cells. In this study, we demonstrate that human primary B cells are able to internalize bacteria when the bacteria are recognized by the BCR. BCR-mediated internalization of Salmonella typhimurium results in B cell differentiation and secretion of anti-Salmonella Ab by the Salmonella-specific B cells. In addition, BCR-mediated internalization leads to efficient Ag delivery to the MHC class II Ag-loading compartments, even though Salmonella remains vital intracellularly in primary B cells. Consequently, BCR-mediated bacterial uptake induces efficient CD4+ T cell help, which boosts Salmonella-specific Ab production. BCR-mediated internalization of Salmonella by B cells is superior over extracellular Ag extraction to induce rapid and specific humoral immune responses and efficiently combat infection.